Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
New drug cocktails aim to shrink tumors before cancer surgery
Disease control Recruiting nowThis study tests whether giving one or two immunotherapy drugs before surgery is safe and can help shrink tumors in people with operable head and neck cancer. About 80 patients will receive either nivolumab alone or combined with another drug (relatlimab or ipilimumab) for a few …
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Could changing when chemo is given boost cancer treatment success?
Disease control Recruiting nowThis study is testing whether changing the timing and frequency of chemotherapy given alongside an immunotherapy drug (pembrolizumab) might work better for people with advanced head and neck cancer that has returned or spread. Researchers think the current standard schedule might…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC